bod-Bruce-Downey

Bruce Downey

DIRECTOR

Bruce Downey has served as a member of our Board of Directors since December 2015. Previously, Bruce was Chairman and Chief Executive Officer of Barr Pharmaceuticals, Inc. (until its acquisition by Teva in 2008), a global generic pharmaceutical manufacturer. He has served on a part-time basis as a Partner of NewSpring Health Capital II, L.P., a venture capital firm, since April 2009. Prior to Barr Pharmaceuticals, Bruce was a practicing attorney for 20 years, working in both the private sector and for the federal government, including the U.S. Department of Justice and the U.S. Department of Energy. In addition, he serves on the boards of directors of OncoPep, Inc., a biotechnology company, and Cardinal Health, Inc., a healthcare services company since April 2011 and July 2009 respectively. Bruce previously served on the board of directors of Melinta Therapeutics, Inc., a biopharmaceutical firm, and Momenta Pharmaceuticals, a biotechnology company acquired by Johnson & Johnson. He holds a B.S. in Economics from Miami University and a J.D. from Ohio State University.